156 related articles for article (PubMed ID: 36011371)
1. Molecular Dynamic Simulation Reveals Structure Differences in
Mayanja R; Kintu C; Diabate O; Soremekun O; Oluwagbemi OO; Wele M; Kalyesubula R; Jjingo D; Chikowore T; Fatumo S
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011371
[TBL] [Abstract][Full Text] [Related]
2. Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1.
Sharma AK; Friedman DJ; Pollak MR; Alper SL
FEBS J; 2016 May; 283(10):1846-62. PubMed ID: 26945671
[TBL] [Abstract][Full Text] [Related]
3. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H; Kumar V; Lan X; Shoshtari SSM; Eng JM; Zhou X; Wang F; Wang H; Skorecki K; Xing G; Wu G; Luo H; Malhotra A; Singhal PC
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29967295
[TBL] [Abstract][Full Text] [Related]
4. APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
Bruggeman LA; O'Toole JF; Sedor JR
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F1-F8. PubMed ID: 30332315
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
[TBL] [Abstract][Full Text] [Related]
6. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
[TBL] [Abstract][Full Text] [Related]
7. APOL1 Genetic Variants Are Associated with Serum-Oxidized Low-Density Lipoprotein Levels and Subclinical Atherosclerosis in South African CKD Patients.
Hassan MO; Duarte R; Dickens C; Dix-Peek T; Naidoo S; Vachiat A; Grinter S; Manga P; Naicker S
Nephron; 2020; 144(7):331-340. PubMed ID: 32526749
[TBL] [Abstract][Full Text] [Related]
8. An Acidic Environment Induces APOL1-Associated Mitochondrial Fragmentation.
Li D; Snipes JA; Murea M; Molina AJA; Divers J; Freedman BI; Ma L; Petrovic S
Am J Nephrol; 2020; 51(9):695-704. PubMed ID: 32866949
[TBL] [Abstract][Full Text] [Related]
9. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
[TBL] [Abstract][Full Text] [Related]
10. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
Olabisi OA; Zhang JY; VerPlank L; Zahler N; DiBartolo S; Heneghan JF; Schlöndorff JS; Suh JH; Yan P; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):830-7. PubMed ID: 26699492
[TBL] [Abstract][Full Text] [Related]
11. Host factors predisposing to kidney disease in people with HIV.
Hung RKY; Winkler CA; Post FA
Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
[TBL] [Abstract][Full Text] [Related]
12. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
13. An African perspective on the genetic risk of chronic kidney disease: a systematic review.
George C; Yako YY; Okpechi IG; Matsha TE; Kaze Folefack FJ; Kengne AP
BMC Med Genet; 2018 Oct; 19(1):187. PubMed ID: 30340464
[TBL] [Abstract][Full Text] [Related]
14. Association of Genetic Polymorphisms of TGF-β1, HMOX1, and APOL1 With CKD in Nigerian Patients With and Without HIV.
Ekrikpo UE; Mnika K; Effa EE; Ajayi SO; Okwuonu C; Waziri B; Bello A; Dandara C; Kengne AP; Wonkam A; Okpechi I
Am J Kidney Dis; 2020 Jul; 76(1):100-108. PubMed ID: 32354559
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
Chun J; Zhang JY; Wilkins MS; Subramanian B; Riella C; Magraner JM; Alper SL; Friedman DJ; Pollak MR
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3712-3721. PubMed ID: 30733285
[TBL] [Abstract][Full Text] [Related]
16. Gene of the month:
Raghubeer S; Pillay TS; Matsha TE
J Clin Pathol; 2020 Aug; 73(8):441-443. PubMed ID: 32404472
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
[TBL] [Abstract][Full Text] [Related]
18. A tripartite complex of suPAR, APOL1 risk variants and α
Hayek SS; Koh KH; Grams ME; Wei C; Ko YA; Li J; Samelko B; Lee H; Dande RR; Lee HW; Hahm E; Peev V; Tracy M; Tardi NJ; Gupta V; Altintas MM; Garborcauskas G; Stojanovic N; Winkler CA; Lipkowitz MS; Tin A; Inker LA; Levey AS; Zeier M; Freedman BI; Kopp JB; Skorecki K; Coresh J; Quyyumi AA; Sever S; Reiser J
Nat Med; 2017 Aug; 23(8):945-953. PubMed ID: 28650456
[TBL] [Abstract][Full Text] [Related]
19. A focus on the association of Apol1 with kidney disease in children.
Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
[TBL] [Abstract][Full Text] [Related]
20. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders.
Adamson WE; Noyes H; Johnson P; Cooper A; Monckton DG; Ogunsola J; Beckett-Hill G; Sullivan M; Mark P; Parekh RS; MacLeod A
EBioMedicine; 2024 Mar; 101():105000. PubMed ID: 38360481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]